NCI Failed to Publish Two Bypass Budgets As Funds Tightened and Sequestration Set In
Guest Editorial: Andrew Vickers on PSA Skepticism, Rational and Irrational
UT Board Announces Support for MD Anderson Tenure System
Study: Drug Discounts Used For Wealthier Patients In Many 340B-Enrolled Hospitals
In Brief: ESMO Names Annual Award Winners
Drugs and Targets: Akynzeo approved for chemotherapy-related nausea
Trending Stories
- OMB proposed rule could end 50% of currently active clinical trials, Stand up for Science analysis finds
- What NHS-Galleri taught us—and what it didn’t
- The NHS-Galleri trial has and will continue to provide critical insights to refine future MCED studies
- FDA clears a way for dramatic reduction in animal toxicology studies in cancer
- Is psilocybin heading to a cancer clinic near you?
Reversing Nixon-era taboo, Trump orders FDA to fast-track psychedelics and ARPA-H to fund research - As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded










